COMPLIMENTARY WEBINAR RECORDINGS
View two complimentary webinars for counsel for brand-name and generic pharmaceutical manufacturers
including a bonus session on GSK v. Teva and The Fate of the Skinny Label.
U.S. Magistrates Judges’ Roundtable on Paragraph IV Litigation: Thoughts on Venue, Discovery, and Settlements
Hon. Tonianne J. Bongiovanni
Magistrate Judge
District of New Jersey
Hon. Roy Payne
Magistrate Judge
Eastern District of Texas
Hatch-Waxman Considerations for Psychedelic Drugs: Strategies for Patenting Mushrooms, Marijuana, and Much More
Paul Simboli
Lead IP Counsel
ATAI Life Sciences
Michael Sitzman
Partner
DLA Piper
Shashank Upadhye
Partner
Upadhye Tang LLP
Attend LIVE and IN-PERSON this April 2022!
Join the conference that the “who’s who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice.
FEATURED 2021 SPEAKERS
Hon. Mitchell Goldberg
District Judge
United States District Court, Eastern District of Pennsylvania
(Visiting Judge, District of Delaware)
Hon. Maryellen Noreika
District Judge
United States District Court, District of Delaware
Hon. Mary Pat Thynge
Chief Magistrate Judge
District of Delaware
Hon. Christopher J. Burke
Magistrate Judge
District of Delaware
Jacqueline Bonilla
Deputy Chief Administrative Patent Judge
Patent Trial & Appeal Board
USPTO
In-person Conference Participation Requirements
As per New York City’s requirements, all attendees and staff are required to provide proof of having received at least one dose of a COVID-19 vaccine. A negative COVID-19 test result will not qualify for entry into the conference. Vaccination proof must be accompanied with a government-issued ID.
In addition, as per the guidance of the CDC, we encourage all attendees to wear a mask or face covering at all times while at the conference and its social functions, except in limited settings such as during meals.
We reserve the right to deny entry to anyone not following the requirements above. Please note our entry policy is subject to change at any time based on changing local, state of federal regulations.
This is the premier conference on Paragraph IV disputes. It consists entirely of high level, in-depth material for experienced practitioners familiar with the nuances of Hatch-Waxman regulatory and litigation practice. The presenters and attendees are all the people who litigate for or work directly for the most active brand and generic companies in the industry. There is no better conference for meeting your counterparts and staying up to speed on the latest developments in this area.
Guy Donatiello
Senior Vice President, Intellectual Property
Endo Pharmaceuticals
I always anticipate attending ACI’s Paragraph IV Disputes Conference. But following such unprecedented times, I’m really excited for this year! Not only will we get the benefit of learnings from distinguished speakers and esteemed colleagues on salient topics, but we will also get to talk about these topics and their practical applicability in person. And, honestly, I just miss seeing everyone.
Pearl Siew
Senior Vice President and Head, Intellectual Property
Design Therapeutics
Concerned About Traveling?
Check out our WORRY-FREE GUARANTEE
Register at the preferred early rate with our worry free cancellation guarantee.
Learn MoreABOUT THIS CONFERENCE
Since 2006, when we launched our inaugural conference, pharmaceutical patent practitioners from throughout the country and in some instances across the globe have attended this conference to confer with each other and assess the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. They also come to hear from Judges — both from the federal judiciary, and U.S. P.T.O.’s PTAB —, the FTC, and the FDA.
Leaders from both brand and generic drug companies recognize that this event is the single forum which serves both sides of the industry and is second to none in offering both legal and economic “take aways” for every sphere of this costly, complex and evolving litigation. This is the only event on market which not only addresses the hot topics, but also puts them within the context of pre-suit considerations, case filings, final adjudication and every step in between. This unique dynamic exemplifies not only the importance of the content and legal theory presented, but the contending business acuities as well.
Come and join our community of Hatch-Waxman practitioners and be part of the only event which shapes the law, policy, and proceedings of Paragraph IV litigation.
WHO YOU WILL MEET
Benchmark, network, and connect with your peers (and opponents) while getting caught up on the latest legal developments, and the shifting legislative and regulatory landscape.
RECORDED EVENTS
Complimentary Session
Examining How New and Narrow Interpretations of the Scope of Patent Term Extension Will Affect Patent Rights and Generic Entry.
ACI’s Global Series of Life Sciences Conferences bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostics, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Learn More
